These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. Massaro M; Scoditti E; Carluccio MA; Pellegrino M; Calabriso N; Storelli C; Martines G; De Caterina R Thromb Haemost; 2013 Feb; 109(2):280-9. PubMed ID: 23238437 [TBL] [Abstract][Full Text] [Related]
4. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Hua Y; Xue J; Sun F; Zhu L; Xie M Pharmacology; 2009; 83(1):18-25. PubMed ID: 18971601 [TBL] [Abstract][Full Text] [Related]
5. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Dragomir E; Tircol M; Manduteanu I; Voinea M; Simionescu M Vascul Pharmacol; 2006 Jun; 44(6):440-9. PubMed ID: 16600694 [TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771 [TBL] [Abstract][Full Text] [Related]
7. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Weyrich AS; Skalabrin EJ; Kraiss LW Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042 [TBL] [Abstract][Full Text] [Related]
8. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells. Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806 [TBL] [Abstract][Full Text] [Related]
10. Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy. Sampson M; Wall S; Baugh M; Worley J; Davies I; Hughes D; Gavrilovic J Diabetes Res Clin Pract; 2006 Jan; 71(1):45-51. PubMed ID: 16023759 [TBL] [Abstract][Full Text] [Related]
11. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
12. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. Zhou H Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541 [TBL] [Abstract][Full Text] [Related]
13. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Zhao L; Bath P; Heptinstall S Br J Pharmacol; 2001 Sep; 134(2):353-8. PubMed ID: 11564653 [TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling. Hong MH; Kim MH; Chang HJ; Kim NH; Shin BA; Ahn BW; Jung YD Life Sci; 2007 May; 80(21):1957-65. PubMed ID: 17379255 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration. Popovic M; Laumonnier Y; Burysek L; Syrovets T; Simmet T J Leukoc Biol; 2008 Jul; 84(1):215-23. PubMed ID: 18436581 [TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Hashimoto K; Ichiyama T; Hasegawa M; Hasegawa S; Matsubara T; Furukawa S Int Arch Allergy Immunol; 2009; 149(3):275-82. PubMed ID: 19218821 [TBL] [Abstract][Full Text] [Related]
18. Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness. Serebruany V; Malinin A; Ziai W; Atar D; Pokov A; Jilma B; Hanley D Cerebrovasc Dis; 2006; 21(1-2):98-105. PubMed ID: 16340184 [TBL] [Abstract][Full Text] [Related]
19. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Amirkhosravi A; Alexander M; May K; Francis DA; Warnes G; Biggerstaff J; Francis JL Thromb Haemost; 1996 Jan; 75(1):87-95. PubMed ID: 8713785 [TBL] [Abstract][Full Text] [Related]
20. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin. Bozzo J; Hernández MR; Ordinas A Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]